Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05049057 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 22, 2024 (before its estimated May 19, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv7
  2. Study sites: 3 to 4v6
  3. Re-verified, no change to tracked fieldsv5
  4. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Start date: Apr 18, 2022 to Jul 19, 2022
    • Study sites: 0 to 3
    • Primary completion date: Dec 15, 2026 to May 19, 2026
    • Study completion date: Dec 15, 2027 to May 19, 2027
  5. Start date: Feb 22, 2022 to Apr 18, 2022v3
  6. Start date: Oct 2021 to Feb 22, 2022v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to assess the effect and safety of erenumab compared to placebo for the treatment of acute posttraumatic headache (PTH) in military service members and civilians with mild traumatic brain injury (mTBI).
Trial Details
NCT Number NCT05049057
Lead Sponsor Henry M. Jackson Foundation for the Advancement of Military Medicine
Conditions
(from sponsor)		 Posttraumatic Headache, Mild Traumatic Brain Injury
Related terms Brain Concussion, Post-Traumatic Headache
Enrollment 404 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov